US Tech 100

19,528.00

0.90%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
RegeneRX Biopharmaceuticals Inc (CE) (RGRX)
RegeneRX Biopharmaceuticals Inc (CE) (RGRX) News

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGRX

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
08/14/2023	4:01PM	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/07/2023	3:57PM	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/11/2023	5:13PM	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/10/2023	5:19PM	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/06/2023	4:35PM	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/06/2023	4:30PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
06/26/2023	6:01AM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
06/21/2023	6:03AM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/15/2023	4:25PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
04/11/2023	4:32PM	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
11/14/2022	4:09PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/12/2022	4:16PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/19/2022	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/19/2022	5:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/19/2022	5:09PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/19/2022	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/19/2022	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
05/16/2022	5:11PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
11/15/2021	4:35PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
11/15/2021	2:56PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
10/18/2021	6:05AM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
10/08/2021	3:52PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/17/2021	10:32AM	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/06/2021	4:09PM	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/04/2021	4:12PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/04/2021	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/04/2021	4:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
08/04/2021	4:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/22/2021	5:01PM	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)
07/19/2021	4:16PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:RGRX	RegeneRX Biopharmaceuticals Inc (CE)